Ammonia N 13

CHEMBL1201189 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
16.0 g/mol
LogP
-0.7
Phase
4

A radioactive form of ammonia used as a tracer during positron emission tomography (PET) scans to evaluate blood flow to the heart muscle. It helps doctors identify areas of reduced circulation that may indicate coronary artery disease.

Peso Molecular

16,0300 g/mol

LogP

-0,70

TPSA

1,00 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[13NH3]

InChI

InChI=1S/H3N/h1H3/i1-1

Molecular Formula

H3N

HBD / HBA

1 / 1

Ligações Rotacionáveis

0

Átomos Pesados

1

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A radioactive form of ammonia used as a tracer during positron emission tomography (PET) scans to evaluate blood flow to the heart muscle. It helps doctors identify areas of reduced circulation that may indicate coronary artery disease.

Yes, Ammonia N 13 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201189. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 119432. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.